Showing 1 - 5 results of 5 for search 'Sarah E Siegelaar', query time: 0.03s Refine Results
  1. 1
    Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence

    Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence by Dion R. P. Muller, Dion R. P. Muller, Dirk J. Stenvers, Dirk J. Stenvers, Arjan Malekzadeh, Frederik Holleman, Rebecca C. Painter, Rebecca C. Painter, Sarah E. Siegelaar, Sarah E. Siegelaar

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes

    Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes by Giulia Frazzei, Giulia Frazzei, Ronald F. van Vollenhoven, Ronald F. van Vollenhoven, Brigit A. de Jong, Sarah E. Siegelaar, Dirkjan van Schaardenburg, Dirkjan van Schaardenburg

    Published 2022-06-01
    Get full text
    Article
  3. 3
    Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol

    Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol by Kaat Beunen, Nancy Van Wilder, Dominique Ballaux, Gerd Vanhaverbeke, Youri Taes, Xavier-Philippe Aers, Frank Nobels, Joke Marlier, Dahae Lee, Joke Cuypers, Vanessa Preumont, Sarah E. Siegelaar, Rebecca C. Painter, Annouschka Laenen, Pieter Gillard, Chantal Mathieu, Katrien Benhalima

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort

    Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort by Femke Rutters, Cees J Tack, Harold W de Valk, J Hans deVries, Miranda T Schram, Coen D A Stehouwer, Bruce H R Wolffenbuttel, Evertine J Abbink, Behiye Özcan, Petra J M Elders, Marieke J Oskam, Sarah E Siegelaar, Marielle Schroijen, Ingrid Jazet, L‘t Hart, N C Schaper, O M Dekkers, B Ozcan, B Silvius, M M van der Klauw

    Published 2020-04-01
    Get full text
    Article
  5. 5
    Dual hormone fully closed loop in type 1 diabetes: a randomised trial in the Netherlands – study protocol

    Dual hormone fully closed loop in type 1 diabetes: a randomised trial in the Netherlands – study protocol by Frank J Snoek, Karel G M Moons, Mirjam M Oosterwerff, Thomas van Bemmel, Catherine B Brouwer, Arianne C van Bon, Harold W de Valk, J Hans deVries, Lioe-Ting Dijkhorst-Oei, Peter R van Dijk, Klaas Hoogenberg, Sarah E Siegelaar, Titia M Vriesendorp, Erik H Serné, Geert W J Frederix, Milena Jancev, Heleen Knottnerus, Helga Blauw, Maureen Witkop, Thomas T van Sloten, Frits A W Kemperman, Lars P Klieverik, Elin Seebus

    Published 2023-08-01
    Get full text
    Article

Search Tools: